Oral Appliance Therapy (OAT) is an FDA approved treatment of mild to moderate obstructive sleep apnea now available for military & veterans. OAT offers a portable, comfortable and effective alternative to bulky CPAP masks, inconvenient devices or invasive surgery. TreatOSA4VA has locations across the country through our divisions Peterson Dental PC and Southwest Sleep Solutions, to serve veterans wherever they live.
MON-FRI 9:00-5:00
Search our national directory
855.244.7533
Members of the military suffer from OSA at over double the rate of the general population.
Obstructive Sleep Apnea (OSA) and other sleep-related breathing disorders are a widespread problem affecting 20-30% of Americans1.
Oral appliance therapy is a small comfortable device you wear in your mouth while sleeping, similar to a retainer or mouth guard.
Call your VA provider or call the VA hospital closest to you to make an appointment.
TreatOSA4VA is a national network of dental providers under the VACCN (VA Community Care Network). Our providers operate under the names Peterson Dental PC (East coast and Midwest) and Southwest Sleep Solutions (Western states, Hawaii and Alaska). Training, clinical oversight and administration powered by Nexus Dental Systems.
Obstructive Sleep Apnea (OSA) and other sleep-related breathing disorders are a widespread problem affecting 20-30% of Americans1. Many of these conditions can be life threatening if not treated, yet often go undiagnosed. Most people don’t even know they suffer from these conditions, or the very real dangers they live with. Good sleep is vital to health, yet millions are deprived of sleep, their sleep cycles interrupted by their body waking up to breathe.
Common symptoms of Obstructive Sleep Apnea include: loud snoring, daytime sleepiness, trouble concentrating, forgetfulness, depression, feeling irritable, night sweats, restless sleep, gasping for air, headaches in morning. If you suffer from any of these symptoms it is critical you get a sleep test to know if you are at risk. .
Sleep apnea is commonly associated with other serious medical conditions like obesity, diabetes, hypertension, heart-failure, stroke, AFib, Alzheimer’s, depression, ADHD. If you already have one of these conditions, OSA can make it worse by placing additional stress on your body and immune system due to lack of restful sleep.
Custom oral appliances are prescribed by a physician and created by a dentist are an FDA approved treatment for mild to moderate OSA and an alternate treatment for CPAP-intolerant or non-compliant cases. Many find oral appliance therapy preferable compared to CPAP, with use rates objectively measured at 83%2
Custom oral appliances prescribed by a physician and created by a trained dentist are an FDA approved treatment for mild to moderate OSA and an alternate treatment for CPAP-intolerant or non-compliant cases. Many find that oral appliances are preferable compared to CPAP, with use rates objectively measured at 83%2. Oral appliances have been shown to be as effective as CPAP on many real-world measures like daytime sleepiness, cognitive performance and high blood pressure.
AMERICAN ADULTS1
OF MIDDLE AGE MEN1
OF ADULT WOMEN1
ARE UNDIAGNOSED1
TreatOSA4VA can provide a variety of telemedicine services depending on your needs. Call 855.244.7533 or email [email protected] for more information.
TreatOSA4VA is developing Remote Monitoring Technologies for compliance management and tracking. Call 855.244.7533 or email [email protected] for more information.
1. Sleep Apnea Statistics and Facts You Should Know, Vanessa Ling, ND, CNS, Medical Reviewer: Chester Wu, MD, Reviewed by: Susan Stiles, PhD, Senior Director of Healthy Aging Innovations at NCOA, NCOA Adviser, Oct 11, 2023, Available online at: https://www.ncoa.org/adviser/sleep/sleep-apnea-statistics/
2.When adherence is defined as greater than 4 hours of nightly use, 46 to 83% of patients with obstructive sleep apnea have been reported to be nonadherent to treatment. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008; 5:173.